Found: 62
Select item for more details and to access through your institution.
Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 7, p. 1157, doi. 10.1007/s00432-017-2389-3
- By:
- Publication type:
- Article
Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 1, p. 123, doi. 10.1007/s00432-016-2262-9
- By:
- Publication type:
- Article
Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. e223, doi. 10.1016/j.clgc.2021.02.004
- By:
- Publication type:
- Article
Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.963411
- By:
- Publication type:
- Article
Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221128356
- By:
- Publication type:
- Article
Identification of characteristic metabolic panels for different stages of prostate cancer by <sup>1</sup>H NMR-based metabolomics analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 3, p. 2129, doi. 10.1002/jcp.29117
- By:
- Publication type:
- Article
Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 3, p. 969, doi. 10.4143/crt.2022.1557
- By:
- Publication type:
- Article
The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43676-3
- By:
- Publication type:
- Article
Integrated Analysis of Transcriptome in Cancer Patient-Derived Xenografts.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0124780
- By:
- Publication type:
- Article
Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The application of "S.I.S" technique improves long‐term continence after robotic radical prostatectomy.
- Published in:
- Neurourology & Urodynamics, 2023, v. 42, n. 3, p. 650, doi. 10.1002/nau.25131
- By:
- Publication type:
- Article
Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.
- Published in:
- International Journal of Nanomedicine, 2019, v. 14, p. 431, doi. 10.2147/IJN.S186226
- By:
- Publication type:
- Article
The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy.
- Published in:
- International Urology & Nephrology, 2023, v. 55, n. 6, p. 1447, doi. 10.1007/s11255-023-03560-x
- By:
- Publication type:
- Article
Structural Optimization of Isoquinoline Derivatives from Lycobetaine and Their Inhibitory Activity against Neuroendocrine Prostate Cancer Cells.
- Published in:
- Molecules, 2024, v. 29, n. 18, p. 4503, doi. 10.3390/molecules29184503
- By:
- Publication type:
- Article
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-01476-1
- By:
- Publication type:
- Article
Engineering the MoS<sub>2</sub>/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens.
- Published in:
- Advanced Science, 2023, v. 10, n. 15, p. 1, doi. 10.1002/advs.202206494
- By:
- Publication type:
- Article
Protoplast Preparation for Algal Single-Cell Omics Sequencing.
- Published in:
- Microorganisms, 2023, v. 11, n. 2, p. 538, doi. 10.3390/microorganisms11020538
- By:
- Publication type:
- Article
The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.527
- By:
- Publication type:
- Article
The Heterogeneous Metabolic Patterns of Ganglia in <sup>68</sup>Ga-PSMA, <sup>11</sup>C-choline, and <sup>18</sup>F-FDG PET/CT in Prostate Cancer Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.666308
- By:
- Publication type:
- Article
Use of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-FDG PET-CT Dual-Tracer to Differentiate Between Lymph Node Metastases and Ganglia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.646110
- By:
- Publication type:
- Article
PRKAR2B‐HIF‐1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
- Published in:
- Cell Proliferation, 2020, v. 53, n. 11, p. 1, doi. 10.1111/cpr.12918
- By:
- Publication type:
- Article
PRKAR2B promotes prostate cancer metastasis by activating Wnt/β‐catenin and inducing epithelial‐mesenchymal transition.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 9, p. 7319, doi. 10.1002/jcb.27030
- By:
- Publication type:
- Article
Production of β-Cyclocitral and Its Precursor β-Carotene in Microcystis aeruginosa : Variation at Population and Single-Cell Levels.
- Published in:
- Toxins, 2022, v. 14, n. 3, p. 201, doi. 10.3390/toxins14030201
- By:
- Publication type:
- Article
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer after Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262411
- By:
- Publication type:
- Article
The added value of <sup>18</sup>F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262250
- By:
- Publication type:
- Article
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer after Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262411
- By:
- Publication type:
- Article
The added value of <sup>18</sup>F-FDG PET/CT compared to <sup>68</sup>Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262250
- By:
- Publication type:
- Article
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer after Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262411
- By:
- Publication type:
- Article
The added value of <sup>18</sup>F-FDG PET/CT compared to <sup>68</sup>Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262250
- By:
- Publication type:
- Article
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer after Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262411
- By:
- Publication type:
- Article
The added value of <sup>18</sup>F-FDG PET/CT compared to <sup>68</sup>Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262250
- By:
- Publication type:
- Article
The added value of <sup>18</sup>F-FDG PET/CT compared to <sup>68</sup>Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262250
- By:
- Publication type:
- Article
The added value of <sup>18</sup>F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.262250
- By:
- Publication type:
- Article
The added value of <sup>18</sup>F-FDG PET/CT compared to <sup>68</sup>Ga-PSMA PET/CT in patients with castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.121.262250
- By:
- Publication type:
- Article
Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 6, p. 567, doi. 10.1002/pros.23762
- By:
- Publication type:
- Article
Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 250, doi. 10.1002/pros.23465
- By:
- Publication type:
- Article
Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone.
- Published in:
- Prostate, 2017, v. 77, n. 12, p. 1233, doi. 10.1002/pros.23381
- By:
- Publication type:
- Article
Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer.
- Published in:
- Prostate, 2017, v. 77, n. 13, p. 1373, doi. 10.1002/pros.23397
- By:
- Publication type:
- Article
Identifying High Gleason Score Prostate Cancer by Prostate Fluid Metabolic Fingerprint‐Based Multi‐Modal Recognition.
- Published in:
- Small Methods, 2024, v. 8, n. 10, p. 1, doi. 10.1002/smtd.202301684
- By:
- Publication type:
- Article
Types of fish consumption differ across socioeconomic strata and impact differently on plasma fish-based omega-3 fatty acids: a cross-sectional study.
- Published in:
- European Journal of Nutrition, 2024, v. 63, n. 2, p. 435, doi. 10.1007/s00394-023-03274-x
- By:
- Publication type:
- Article
Associations of 24 h urinary excretions of α- and γ-carboxyethyl hydroxychroman with plasma α- and γ-tocopherol and dietary vitamin E intake in older adults: the Lifelines-MINUTHE Study.
- Published in:
- European Journal of Nutrition, 2022, v. 61, n. 7, p. 3755, doi. 10.1007/s00394-022-02918-8
- By:
- Publication type:
- Article
HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 12, p. 3060, doi. 10.1002/ijc.33494
- By:
- Publication type:
- Article
Surface-enhanced Raman spectroscopy of serum predicts sensitivity to docetaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Innovative Optical Health Sciences, 2021, v. 14, n. 4, p. 1, doi. 10.1142/S1793545821410066
- By:
- Publication type:
- Article
Effects of Education and Income on Incident Type 2 Diabetes and Cardiovascular Diseases: a Dutch Prospective Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Baseline PSMA‐PET/CT as a predictor of PSA persistence following radical prostatectomy in high‐risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy.
- Published in:
- Prostate, 2023, v. 83, n. 11, p. 1112, doi. 10.1002/pros.24553
- By:
- Publication type:
- Article
The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy.
- Published in:
- Prostate, 2021, v. 81, n. 8, p. 463, doi. 10.1002/pros.24126
- By:
- Publication type:
- Article
High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1085569
- By:
- Publication type:
- Article
Separate and combined effects of individual and neighbourhood socio-economic disadvantage on health-related lifestyle risk factors: a multilevel analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article